Back to News
Market Impact: 0.24

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

LCTX
Corporate EarningsCompany FundamentalsAnalyst EstimatesHealthcare & Biotech

Lineage Cell reported a quarterly loss of $0.03 per share, missing the Zacks consensus estimate of a $0.02 loss and widening from a $0.02 loss a year ago. The report is a modest earnings disappointment, with limited macro relevance but potential stock-specific pressure.

Analysis

Lineage Cell reported a quarterly loss of $0.03 per share, missing the Zacks consensus estimate of a $0.02 loss and widening from a $0.02 loss a year ago. The report is a modest earnings disappointment, with limited macro relevance but potential stock-specific pressure.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.18

Ticker Sentiment

LCTX-0.35